Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $36.1 billion.

  • Fresenius Medical Care AG's Liabilities and Shareholders Equity rose 113.26% to $36.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $141.8 billion, marking a year-over-year decrease of 286.48%. This contributed to the annual value of $35.9 billion for FY2024, which is 174.64% down from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Liabilities and Shareholders Equity of $36.1 billion as of Q3 2025, which was up 113.26% from $35.4 billion recorded in Q2 2025.
  • Fresenius Medical Care AG's 5-year Liabilities and Shareholders Equity high stood at $40.0 billion for Q1 2021, and its period low was $58.0 million during Q4 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $37.3 billion (2024), whereas its average is $35.5 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 7420.66% in 2021, then surged by 6281995.2% in 2022.
  • Over the past 5 years, Fresenius Medical Care AG's Liabilities and Shareholders Equity (Quarter) stood at $58.0 million in 2021, then surged by 62819.95% to $36.5 billion in 2022, then rose by 0.08% to $36.5 billion in 2023, then fell by 1.75% to $35.9 billion in 2024, then increased by 0.67% to $36.1 billion in 2025.
  • Its Liabilities and Shareholders Equity was $36.1 billion in Q3 2025, compared to $35.4 billion in Q2 2025 and $34.4 billion in Q1 2025.